Treatment and survival of second primary early-stage lung cancer, following treatment of head and neck cancer in the Netherlands

• Published in: Lung cancer (Amsterdam, Netherlands) Vol. 94; pp. 54 - 60
• Main Authors: Louie, Alexander V, Damhuis, Ronald A, Haasbeek, Cornelis J, Warner, Andrew, Rodin, Danielle, Slotman, Ben J, Leemans, C.Rene, Senan, Suresh
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier Ireland Ltd 01.04.2016
• Subjects: Aged; Combined Modality Therapy - adverse effects; Combined Modality Therapy - methods; Female; Head and Neck Neoplasms - epidemiology; Head and Neck Neoplasms - mortality; Head and Neck Neoplasms - therapy; Hematology, Oncology and Palliative Medicine; Humans; Lung cancer; Lung Neoplasms - epidemiology; Lung Neoplasms - etiology; Lung Neoplasms - mortality; Lung Neoplasms - therapy; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary - epidemiology; Neoplasms, Second Primary - etiology; Neoplasms, Second Primary - mortality; Neoplasms, Second Primary - therapy; Netherlands - epidemiology; Population study; Population Surveillance; Proportional Hazards Models; Pulmonary/Respiratory; Registries; Stereotactic ablative radiotherapy; Surveillance; Survivorship; Surveillance; Survivorship; Population study; Lung cancer; Stereotactic ablative radiotherapy
• ISSN: 0169-5002; 1872-8332
• DOI: 10.1016/j.lungcan.2016.01.022

Highlights • Surveillance for second primary lung cancer (SPLC) is important in head and neck cancer survivorship. • In early-stage SPLC, both SABR and surgery are potentially curative modalities. • Distinguishing between early-stage SPLC and a metastasis can be challenging. • Radical treatment in either situation can be associated with prolonged survival.